Angeles Investment Advisors, LLC Dexcom Inc Transaction History

Angeles Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$64.0 - $116.06 $40,960 - $74,278	-640 Reduced 10.77%	5,300 $355,000
Q2 2024 Aug 09, 2024	BUY	$110.31 - $140.45 $10,258 - $13,061	93 Added 1.59%	5,940 $673,000
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $240,547 - $295,050	-2,106 Reduced 26.48%	5,847 $810,000
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $70,130 - $115,344	929 Added 13.23%	7,953 $986,000
Q3 2023 Nov 09, 2023	BUY	$86.06 - $137.93 $604,485 - $968,820	7,024 New	7,024 $655,000

1,085

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Angeles Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Angeles Investment Advisors, LLC with notifications on news.